Furthermore, increased Arg1 activity by Th2 cytokines dampened lung immunity against bacterial infections in mice, suggesting Arg1 blockade as a therapeutic intervention to lower lung infections in asthmatic patients (52). This evidence concerns the gene ARG1 and bacterial infectious disease.